SCHEMBL30107826

SCHEMBL30107826

c1ccc(-c2cc(-c3ccccc3)nc(-c3cc(-n4c5ccc(-c6cccnc6)cc5c5cc(-c6cccnc6)ccc54)cc(-n4c5ccc(-c6cccnc6)cc5c5cc(-c6cccnc6)ccc54)c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.44
▸ CYP11B1 P15538 5/20 0.43
▸ CYP11B2 P19099 5/20 0.43
▸ CYP19A1 P11511 4/20 0.43
▸ CYP17A1 P05093 1/20 0.43
▸ GRM5 P41594 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ NR4A2 P43354 1/20 0.38
▸ NTSR1 P30989 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ KMO O15229 1/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30107757 0.96 DHODH (0.43) DHODHCYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL30107765 0.93 DHODH (0.43) DHODHCYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL30107747 0.93 CYP11B1 (0.46) CYP11B1CYP11B2CYP19A1CYP17A1MEN1
SCHEMBL17853604 0.90 CYP19A1 (0.47) DHODHCYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL30107846 0.89 CYP11B1 (0.43) DHODHCYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL19486549 0.89 DHODH (0.44) DHODHCYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL19486758 0.89 DHODH (0.44) DHODHCYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL30107714 0.88 MEN1 (0.45) DHODHMEN1KMT2AALDH1A1NTSR1
SCHEMBL30107851 0.88 MEN1 (0.45) DHODHMEN1KMT2AALDH1A1NTSR1
SCHEMBL17227948 0.88 MKNK1 (0.41) DHODHGRM5MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542260-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542260-B2 Composition of matter for use in organic light-emitting diodes CRY2, NDUFV3, SLCO1B3 DHODH 1052/4885CYP11B1 1726/4885CYP11B2 1026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback